High-performance liquid chromatographic analysis of idarubicin and fluorescent metabolites in biological fluids

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.

Aiman N. Daghestani, Zalmen A. Arlin, Brian Leyland‐Jones et al. · PubMed · 1985 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +15

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.

Ellin Berman, Robert E. Wittes, Brian Leyland‐Jones et al. · PubMed · 1983 · 73 citations

Medicine, Oncology, Pharmacology +11

Pharmacokinetics of idarubicin (4‐demethoxydaunorubicin; IMI‐30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.

HC Gillies, Deborah Herriott, Raymond Liang et al. · British Journal of Clinical Pharmacology · 1987 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Gel chromatography of oligosaccharides up to dp 60

Michael John, Jürgen Schmidt, Christian Wandrey et al. · Journal of Chromatography A · 1982 · 45 citations

Life Sciences, Biochemistry, Carbohydrate Biochemistry +9

Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

Katherine Lu, Niramol Savaraj, John J. Kavanagh et al. · Cancer Chemotherapy and Pharmacology · 1986 · 45 citations

Medicine, Medicinal Chemistry, Pharmacology +10